Literature DB >> 17224651

p63-associated disorders.

Tuula Rinne1, Hans G Brunner, Hans van Bokhoven.   

Abstract

Heterozygous mutations in the transcription factor gene p63 are causative for several syndromes, with ectodermal dysplasia, orofacial clefting and limb malformations as the key characteristics. Different combinations of these features are seen in five different syndromes, of which ectrodactyly, ectodermal dysplasia and cleft lip/palate syndrome (EEC) is the most common one. Mutations in p63 can also cause non-syndromic single malformations, such as split hand foot malformation (SHFM4) and isolated cleft lip (NSCL). In this article we will present an overview of diseases caused by mutations in the p63 gene and review the known pathogenic p63 gene mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17224651     DOI: 10.4161/cc.6.3.3796

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  94 in total

1.  p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels.

Authors:  Simon S McDade; Daksha Patel; Dennis J McCance
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

2.  Pliable DNA conformation of response elements bound to transcription factor p63.

Authors:  Chen Chen; Natalia Gorlatova; Osnat Herzberg
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

3.  New functions for the Snail family of transcription factors: Two-faced proteins.

Authors:  Jesús Pérez-Losada; Isidro Sanchez-Garcia
Journal:  Cell Cycle       Date:  2010-07-15       Impact factor: 4.534

Review 4.  p63 and p73, the ancestors of p53.

Authors:  V Dötsch; F Bernassola; D Coutandin; E Candi; G Melino
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-05-19       Impact factor: 10.005

5.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

Review 6.  Therapeutic prospects for p73 and p63: rising from the shadow of p53.

Authors:  Anna Vilgelm; Wael El-Rifai; Alexander Zaika
Journal:  Drug Resist Updat       Date:  2008-09-17       Impact factor: 18.500

7.  2008 International Conference on Ectodermal Dysplasias Classification: conference report.

Authors:  Carlos F Salinas; Ronald J Jorgenson; J Timothy Wright; John J DiGiovanna; Mary D Fete
Journal:  Am J Med Genet A       Date:  2009-09       Impact factor: 2.802

8.  Structures of p63 DNA binding domain in complexes with half-site and with spacer-containing full response elements.

Authors:  Chen Chen; Natalia Gorlatova; Zvi Kelman; Osnat Herzberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

Review 9.  Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.

Authors:  Maranke I Koster; Jason Dinella; Jiangli Chen; Charlene O'Shea; Peter J Koch
Journal:  Cell Commun Adhes       Date:  2014-02

10.  Novel mutation in TP63 associated with ectrodactyly ectodermal dysplasia and clefting syndrome and T cell lymphopenia.

Authors:  Philip F Giampietro; Mei W Baker; Monica J Basehore; Julie R Jones; Christine M Seroogy
Journal:  Am J Med Genet A       Date:  2013-04-23       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.